Rothschild Investment Corp IL increased its position in Medtronic PLC (NYSE:MDT) by 30.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,554 shares of the medical technology company’s stock after buying an additional 5,078 shares during the quarter. Rothschild Investment Corp IL’s holdings in Medtronic were worth $1,676,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in MDT. Parkside Financial Bank & Trust lifted its holdings in shares of Medtronic by 22.4% in the second quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock valued at $102,000 after buying an additional 210 shares during the period. BDO Wealth Advisors LLC acquired a new stake in shares of Medtronic in the second quarter valued at $103,000. Motco lifted its holdings in shares of Medtronic by 8.7% in the second quarter. Motco now owns 1,239 shares of the medical technology company’s stock valued at $110,000 after buying an additional 99 shares during the period. Quadrant Capital Group LLC lifted its holdings in shares of Medtronic by 21.5% in the second quarter. Quadrant Capital Group LLC now owns 1,639 shares of the medical technology company’s stock valued at $114,000 after buying an additional 290 shares during the period. Finally, Israel Discount Bank of New York purchased a new stake in shares of Medtronic during the first quarter valued at $117,000. Institutional investors and hedge funds own 81.85% of the company’s stock.
Several equities research analysts have recently commented on MDT shares. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 target price on shares of Medtronic in a report on Thursday, November 9th. BidaskClub downgraded Medtronic from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. Zacks Investment Research downgraded Medtronic from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. SunTrust Banks set a $92.00 target price on Medtronic and gave the company a “buy” rating in a report on Sunday, November 19th. Finally, Royal Bank Of Canada reduced their target price on Medtronic from $90.00 to $85.00 and set an “outperform” rating for the company in a report on Monday, October 9th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $88.02.
Medtronic PLC (NYSE:MDT) traded down $0.77 during trading hours on Thursday, reaching $80.73. The company had a trading volume of 2,719,837 shares, compared to its average volume of 4,960,256. The firm has a market capitalization of $109,525.05, a price-to-earnings ratio of 17.44, a price-to-earnings-growth ratio of 2.23 and a beta of 1.00. Medtronic PLC has a 52-week low of $69.35 and a 52-week high of $89.72. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50.
Medtronic (NYSE:MDT) last posted its quarterly earnings results on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.99 by $0.08. The firm had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. Medtronic’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.12 earnings per share. sell-side analysts anticipate that Medtronic PLC will post 4.77 earnings per share for the current year.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.